ERYTHROMYCIN AND BENZOYL PEROXIDE
Generic: ERYTHROMYCIN AND BENZOYL PEROXIDE
Rising Pharma HoldingsManufacturer
TOPICALRoute
ERYTHROMYCINActive Substance
2015-09-18Original Approval
ERYTHROMYCIN AND BENZOYL PEROXIDE is FDA application ANDA065385, sponsored by RISING. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2026-04-29
Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intak
Class II2026-04-29
Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intak
Top Reported Reactions
1
DRUG HYPERSENSITIVITY
4,122 reports
2
NAUSEA
1,307 reports
3
VOMITING
1,144 reports
4
DRUG INEFFECTIVE
1,126 reports
5
DIARRHOEA
1,104 reports
6
DYSPNOEA
1,068 reports
7
FATIGUE
1,067 reports
8
RASH
1,041 reports
9
OFF LABEL USE
972 reports
10
HEADACHE
890 reports